PI
PCRX icon

Putnam Investments’s Pacira BioSciences PCRX Stock Holding History

Putnam Investments’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-75,767
Closed -$4.03M – 1179
2022
Q3 		$4.03M Sell
75,767
-10,096
-12% -$561K 0.01% 485
2022
Q2 		$5.01M Buy
85,863
+19,121
+29% +$1.25M 0.01% 439
2022
Q1 		$5.09M Buy
+66,742
New +$4.45M 0.01% 494
2018
Q2 		– Sell
-464,039
Closed -$14.5M – 1161
2018
Q1 		$14.5M Sell
464,039
-172,149
-27% -$6.13M 0.03% 317
2017
Q4 		$29M Sell
636,188
-9,876
-2% -$391K 0.06% 225
2017
Q3 		$24.3M Sell
646,064
-8,110
-1% -$326K 0.06% 239
2017
Q2 		$31.2M Buy
654,174
+187,558
+40% +$8.7M 0.07% 210
2017
Q1 		$21.3M Buy
466,616
+432,067
+1,251% +$18.7M 0.05% 276
2016
Q4 		$1.12M Buy
34,549
+5,410
+19% +$181K ﹤0.01% 983
2016
Q3 		$997K Sell
29,139
-53,772
-65% -$2.11M ﹤0.01% 1021
2016
Q2 		$2.8M Buy
82,911
+41,377
+100% +$2.03M 0.01% 832
2016
Q1 		$2.2M Sell
41,534
-32,585
-44% -$1.91M 0.01% 924
2015
Q4 		$5.69M Sell
74,119
-76,981
-51% -$4.36M 0.01% 617
2015
Q3 		$6.21M Sell
151,100
-41,662
-22% -$2.55M 0.01% 596
2015
Q2 		$13.6M Buy
192,762
+18,592
+11% +$1.46M 0.03% 402
2015
Q1 		$15.5M Buy
+174,170
New +$17.7M 0.03% 394

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Putnam Investments's PCRX Position: Q4 2022 in Review

Putnam Investments sold out of Pacira BioSciences (PCRX) in Q4 2022, closing a stake of 75,767 shares — an estimated $4.03M sold.

Putnam Investments first reported a position in PCRX in Q1 2015 and held it in 16 quarters. The position peaked at $31.2M in Q2 2017. 273 funds tracked by Wall St. Rank hold PCRX as of Q4 2022.

  • Putnam Investments reported no remaining Pacira BioSciences position as of Q4 2022 after selling out during the quarter.
  • Putnam Investments sold 75,767 Pacira BioSciences shares in Q4 2022, an estimated $4.03M.
  • Putnam Investments first reported a position in Pacira BioSciences in Q1 2015 and held it in 16 quarters.
  • Putnam Investments's Pacira BioSciences position peaked at $31.2M in Q2 2017.
  • 273 funds tracked by Wall St. Rank held Pacira BioSciences as of Q4 2022.

Based on Putnam Investments's 13F filing for Q4 2022, filed 14 Feb 2023.